Softbank Vision Fund 2 led a $150m financing round in EDDA Technology, a provider and developer of intelligent robotic solutions for precision surgery. The round also had participation from OrbiMed and 3wVentures and existing investors including Morningside Ventures, Matrix Partners China, SBCVC, BOCGI, Trust Bridge and Draper Dragon. "This round of investment from Softbank Vision Fund 2, OrbiMed and 3W with their vision and market insight, will further accelerate the company's strategic growth, and further support the company to continuously lead technological innovation in precision surgery, capture the untapped market of intelligent surgical robots including hospitals in second- and third-tier cities, and utilize technologies to facilitate the diagnosis and treatment of major diseases such as cancer," Dr. Jianzhong Qian, EDDA Technology President and CEO.